Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Published in: The journal of nutrition, health & aging 5/2021

Open Access 01-05-2021 | Nutrition

Nutritional Interventions for Early Dementia

Authors: Matteo Cesari, D. Azzolino, B. Arosio, M. Canevelli

Published in: The journal of nutrition, health & aging | Issue 5/2021

Login to get access

Abstract

Nutrition plays a critical role in the definition of the individual’s wellbeing. Nutritional interventions have been repeatedly advocated as of potential interest for preventing or delaying the cognitive decline, also in the context of neurodegenerative conditions. The idea of targeting the initial phases of dementia, when the process is theoretically still amenable of correction, via lifestyle modifications (including healthy diet or supplementation of specific micro-/macro-nutrients) is extremely appealing. In this perspective paper, we describe the most recent evidence on the topic and discuss how the nutritional assessment should be nested within a comprehensive approach to the aging person with initial signs of dementia for promoting his/her optimal management.
Literature
1.
Volkert D, Chourdakis M, Faxen-Irving G et al. ESPEN guidelines on nutrition in dementia. Clin Nutr 2015; 34: 1052–1073.CrossRef
2.
Calvani R, Miccheli A, Landi F et al. Current nutritional recommendations and novel dietary strategies to manage sarcopenia. J Frailty Aging 2013; 2: 16.
3.
Jung S, Hermann J, Bishop A. Impact of nutritional risk on self-care capacity: social support as a source of protection for community-dwelling older adults living in a rural area. J Frailty Aging 2013; 2: 145–149.PubMed
4.
Landi F, Sieber C, Fielding RA, Rolland Y, Guralnik J, The ICFSR Task Force. Nutritional Intervention in Sarcopenia: Report from the International Conference on Frailty and Sarcopenia Research Task Force. J Frailty Aging 2018; 7: 247–252.PubMed
5.
Burgener SC, Buettner L, Buckwalter KC et al. Evidence supporting nutritional interventions for persons in early stage Alzheimer’s disease (AD). J Nutr Health Aging 2008; 12: 18–21.CrossRef
6.
Gillette Guyonnet S, Abellan Van Kan G, Andrieu S et al. IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging 2007; 11: 132–152.PubMed
7.
The Orlando Frailty Conference Group. Raising awareness on the urgent need to implement frailty into clinical practice. J Frailty Aging 2013; 2: 121–124.PubMedCentral
8.
Kelaiditi E, Cesari M, Canevelli M et al. Cognitive frailty: rational and definition from an IANA-IAGG international consensus group. J Nutr Health Aging 2013; 17: 726–734.CrossRef
9.
Doorduijn AS, de van der Schueren MAE, van de Rest O et al. Olfactory and gustatory functioning and food preferences of patients with Alzheimer’s disease and mild cognitive impairment compared to controls: the NUDAD project. J Neurol 2020; 267: 144–152.CrossRef
10.
Olde Rikkert MGM, Verhey FR, Sijben JWC et al. Differences in Nutritional Status Between Very Mild Alzheimer’s Disease Patients and Healthy Controls. J Alzheimers Dis 2014; 41: 261–271.CrossRef
11.
Doorduijn AS, van de Rest O, van der Flier WM, Visser M, de van der Schueren MAE. Energy and Protein Intake of Alzheimer’s Disease Patients Compared to Cognitively Normal Controls: Systematic Review. Journal of the American Medical Directors Association 2019; 20: 14–21.CrossRef
12.
Wang R, Yan Z, Liang Y et al. Prevalence and Patterns of Chronic Disease Pairs and Multimorbidity among Older Chinese Adults Living in a Rural Area. PLoS One 2015; 10: e0138521.CrossRef
13.
Abad-Díez J, Calderón-Larrañaga A, Poncel-Falcó A et al. Age and gender differences in the prevalence and patterns of multimorbidity in the older population. BMC Geriatr 2014; 14: 75.CrossRef
14.
Bauer J, Biolo G, Cederholm T et al. Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group. J Am Med Dir Assoc 2013; 14: 542–559.CrossRef
15.
Deutz N, Bauer J, Barazzoni R et al. Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group. Clin Nutr 2014; 33: 929–936.CrossRef
16.
de Kerimel J, Tavassoli N, Lafont C et al. How to Manage Frail Older Adults in the Community? Proposal of a Health Promotion Program Experienced in a City of 16,638 Inhabitants in France. J Frailty Aging 2018; 7: 120–126.PubMed
17.
Jesus P, Desport J, Massoulard A et al. Nutritional assessment and follow-up of residents with and without dementia in nursing homes in the limousin region of France: a health network initiative. J Nutr Health Aging 2012; 16: 504–508.CrossRef
18.
Cesari M, Incalzi R, Zamboni V, Pahor M. Vitamin D hormone: A multitude of actions potentially influencing the physical function decline in older persons. Geriatr Gerontol Int 2011; 11: 133–142.CrossRef
19.
Basile M, Ciardi L, Crespi I, Saliva E, Bellomo G, Vidali M. Assessing serum concentrations of 25-hydroxy-vitamin D in North-Western Italy. J Frailty Aging 2013; 2: 174–178.PubMed
20.
Hamilton B. Vitamin D and Human Skeletal Muscle. Scandinavian Journal of Medicine & Science in Sports 2009
21.
Hooshmand B, Lokk J, Solomon A et al. Vitamin D in Relation to Cognitive Impairment, Cerebrospinal Fluid Biomarkers, and Brain Volumes. J Gerontol A Biol Sci Med Sci 2014; 69: 1132–1138.CrossRef
22.
Volkert D, Saeglitz C, Gueldenzoph H, Sieber C, Stehle P. Undiagnosed malnutrition and nutrition-related problems in geriatric patients. J Nutr Health Aging 2010; 14: 387–392.CrossRef
23.
Kaiser M, Bauer J, Rämsch C et al. Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J Am Geriatr Soc 2010; 58: 1734–1738.CrossRef
24.
Ponjoan A, Garre-Olmo J, Blanch J et al. Epidemiology of dementia: prevalence and incidence estimates using validated electronic health records from primary care. Clin Epidemiol 2019; 11: 217–228.CrossRef
25.
Vandewoude MFJ, van Wijngaarden JP, De Maesschalck L, Luiking YC, Van Gossum A. The prevalence and health burden of malnutrition in Belgian older people in the community or residing in nursing homes: results of the NutriAction II study. Aging Clin Exp Res 2019; 31: 175–183.CrossRef
26.
Guigoz Y. Frailty and nutrition: what we have learned from research and clinical practice on the Mini Nutritional Assessment. J Frailty Aging 2012; 1: 52–55.PubMed
27.
Nieuwenhuizen W, Weenen H, Rigby P, Hetherington M. Older adults and patients in need of nutritional support: review of current treatment options and factors influencing nutritional intake. Clin Nutr (Edinburgh, Scotland) 2010; 29: 160–169.CrossRef
28.
Jadczak AD, Visvanathan R. Anorexia of Aging — An Updated Short Review. J Nutr Health Aging 2019; 23: 306–309.CrossRef
29.
Cox NJ, Morrison L, Ibrahim K, Robinson SM, Sayer AA, Roberts HC. New horizons in appetite and the anorexia of ageing. Age Ageing 2020; 49: 526–534.CrossRef
30.
Probert N, Lööw A, Akner G, Wretenberg P, Andersson ÅG. A Comparison of Patients with Hip Fracture, Ten Years Apart: Morbidity, Malnutrition and Sarcopenia. J Nutr Health Aging 2020; 24: 870–877.CrossRef
31.
Correia M, Hegazi R, Higashiguchi T et al. Evidence-based recommendations for addressing malnutrition in health care: an updated strategy from the feedM.E. Global Study Group. J Am Med Dir Assoc 2014; 15: 544–550.CrossRef
32.
Thomas D, Ashmen W, Morley J, Evans W. Nutritional management in long-term care: development of a clinical guideline. Council for Nutritional Strategies in Long-Term Care. J Gerontol A Biol Sci Med Sci 2000; 55: M725–34.CrossRef
33.
Nutrition and dementia: A review of available research. London, United Kingdom: Alzheimer’s Disease International, 2014.
34.
World report on ageing and health. Geneva, Switzerland: World Health Organization, 2015.
35.
Soysal P, Dokuzlar O, Erken N, Dost Günay FS, Isik AT. The Relationship Between Dementia Subtypes and Nutritional Parameters in Older Adults. J Am Med Dir Assoc 2020
36.
Edington J, Barnes R, Bryan F et al. A prospective randomised controlled trial of nutritional supplementation in malnourished elderly in the community: clinical and health economic outcomes. Clin Nutr 2004; 23: 195–204.CrossRef
37.
Meijers J, Candel M, Schols J, van Bokhorst-de van der Schueren M, Halfens R. Decreasing trends in malnutrition prevalence rates explained by regular audits and feedback. J Nutr 2009; 139: 1381–1386.CrossRef
38.
Integrated care for older people (ICOPE): Guidance for person-centred assessment and pathways in primary care. World Health Organization, 2019.
39.
Marzetti E, Sanna T, Calvani R, Bernabei R, Landi F, Cesari M. Brand New Medicine for an Older Society. J Am Med Dir Assoc 2016; 17: 558–559.CrossRef
40.
Rolfson DB, Heckman GA, Bagshaw SM, Robertson D, Hirdes JP, Canadian Frailty Network. Implementing Frailty Measures in the Canadian Healthcare System. J Frailty Aging 2018; 7: 208–216.PubMed
41.
Sanchez-Rodriguez D, Annweiler C, Gillain S, Vellas B. Implementation of the Integrated Care of Older People (ICOPE) App in Primary Care: New Technologies in Geriatric Care During Quarantine of COVID-19 and Beyond. J Frailty Aging 2020
42.
Cummings J, Passmore P, McGuinness B et al. Souvenaid in the management of mild cognitive impairment: an expert consensus opinion. Alz Res Therapy 2019; 11: 73.CrossRef
43.
Scheltens P, Twisk JWR, Blesa R et al. Efficacy of Souvenaid in Mild Alzheimer’s Disease: Results from a Randomized, Controlled Trial. J Alzheimers Dis 2012; 31: 225–236.CrossRef
44.
Scheltens P, Kamphuis PJGH, Verhey FRJ et al. Efficacy of a medical food in mild Alzheimer’s disease: A randomized, controlled trial. Alzheimers Dement 2010; 6: 1–10.e1.CrossRef
45.
Soininen H, Solomon A, Visser PJ et al. 24-month intervention with a specific multinutrient in people with prodromal Alzheimer’s disease (LipiDiDiet): a randomised, double-blind, controlled trial. Lancet Neurol 2017; 16: 965–975.CrossRef
Metadata
Title
Nutritional Interventions for Early Dementia
Authors
Matteo Cesari
D. Azzolino
B. Arosio
M. Canevelli
Publication date
01-05-2021
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 5/2021
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-021-1616-4

Other articles of this Issue 5/2021

The journal of nutrition, health & aging 5/2021 Go to the issue

OriginalPaper

Predictive Value of the GLIM Criteria in Chinese Community-Dwelling and Institutionalized Older Adults Aged 70 Years and Over

OriginalPaper

We Need to Know: A Call for Interdisciplinary Education on COVID-19

OriginalPaper

Pan-European Study on Functional and Medical Recovery and Geriatric Rehabilitation Services of Post-COVID-19 Patients: Protocol of the EU-COGER Study

OriginalPaper

Success of Simpler Modified Fried Frailty Scale to Predict Mortality among Nursing Home Residents

OriginalPaper

Description of Participants in the “Atout Age Mobility” Prevention Workshops at the University Hospital Center of La Reunion: A Prospective Study

ReviewPaper

The Impact of Frailty on COVID-19 Outcomes: A Systematic Review and Meta-analysis of 16 Cohort Studies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits